Commercialization: Page 70
-
PharmaVoice Team/PharmaVoice
The Crusade for Brand Relevance
I recently realized that I have a love-hate relationship with a few things in my life. Oreo Cookie Blizzards, reality TV, my iPad, my mobile phone, and my computer. I love them at the time of use or indulgence, but inevitably pay for them later in the form of calories, time wasting, or the feelin...
By PharmaVoice Team • Oct. 12, 2010 -
PharmaVoice Team/PharmaVoice
A Surround Sound Perspective on Comparative Effectiveness
As the industry waits for the FDA’s implementation plan for comparative effectiveness research, the senior executives of The Core Nation (Core-Create/Brandkarma/Alpha & Omega) offer a multifaceted perspective on the brand implications of this new regulatory mandate. Ken Kramer, Ph.D. Senior V...
By PharmaVoice Team • Oct. 12, 2010 -
PharmaVoice Team/PharmaVoice
What Patients Want
We spend the great part of our days at Catalina helping our clients communicate with their end customer, the patient who actually takes the drug they market. For some members of the brand team it’s a new and unique experience. Many have spent their time either focused on the health care provider ...
By PharmaVoice Team • Oct. 12, 2010 -
PharmaVoice Team/PharmaVoice
Supplier Showcase
Supplier Showcase Featured Product and Service Showcases Catalina Health Resource Core-Create ERA Clinical LLC GA Communication Group Guard Dog Brand Development LLC IPAK J. Knipper and Company Inc. LLNS Lnx Pharma Observant LLC Ogilvy CommonHealth Worldwide PARTNERS+simons SDI SK&A The Medic...
By PharmaVoice Team • Oct. 12, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Marketers — on both the client and agency side — face more challenges than ever before as they endeavor to bring their brands to life. The issues vying for clients’ attention inlcude channel proliferation; an awakened FDA testing its regulatory muscle; shifting competitive landscapes driven by up...
By PharmaVoice Team • Oct. 12, 2010 -
PharmaVoice Team/PharmaVoice
Comparative Effectiveness: Real-World Evidence of Outcomes
Comparative effectiveness research is going to have a huge impact on every stakeholder in healthcare delivery. It requires a much broader view of the healthcare system so that information will exist about a patient’s outcome as he or she moves from diagnosis to treatment in the healthcare system....
By PharmaVoice Team • Aug. 27, 2010 -
PharmaVoice Team/PharmaVoice
Comparative Effectiveness Research — Watch and Worry or Weigh In and Leverage?
A little-publicized provision of the American Recovery and Reinvestment Act of 2009 is likely to have at least as big, if not a bigger, long-term impact on the pharmaceutical and medical device business as the recently passed Affordable Care Act. This provision allocated $1.1 billion for comparat...
By Dr. Ramana Yalamanchili • Aug. 27, 2010 -
PharmaVoice Team/PharmaVoice
View on Med Ed: Refining the Formula
Amid public protests from high-profile figures such as former AHA President Clyde Yancy, M.D., and National Institutes of Health Director Francis Collins, M.D., Ph.D., in June the Accreditation Council for Continuing Medical Education (ACCME) provided additional guidance to its 2004 Standards for...
By Carolyn Gretton • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Nichebusters vs.Blockbusters
Transformation in the industry is everywhere, driven by healthcare reform, increased regulatory scrutiny, patent expiry cliffs, and thinning pipelines. The old ways of doing anything — drug development, drug research, sales, marketing, launch activities, market research — are no longer effective ...
By Robin Robinson • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Midlevel Healthcare Providers: An Untapped Prescribing Force
Billions of prescriptions — and millions of dollars — are being influenced by a group of individuals who go largely untapped when it comes to communications, outreach, and education. Nurse practitioners (NPs) and physician assistants (PAs) wrote 7.8% of U.S. prescriptions — 308 million from June ...
By Denise Myshko • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Lonnel COATS Eisai Names CEO for U.S. Subsidiary Eisai Inc., a U.S. subsidiary of Japan’s Eisai Co., has promoted Lonnel Coats to president and CEO, from president and chief operating officer. In addition, Mr. Coats has been appointed senior VP of Eisai Co.’s pharmaceuticals b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Pharma Could Benefit from Earlier Planning of Counter-Generics Strategies Sidebars: Counter-Generics Strategies Used by All Companies in Past 3 Years (2008-2010) Changes in Medical Treatment in Past Year Due to Economic ...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
What's New
Barnett Educational Services has announced the release of updated editions of three of its market intelligence and clinical practices guides. PAREXEL’S BIOPHARMACEUTICAL R&D STATISTICAL SOURCEBOOK 2010/2011 includes statistics, trends, and proprietary market intelligence and analysis on the b...
By PharmaVoice Team • Aug. 26, 2010 -
PharmaVoice Team/PharmaVoice
The Reading List
FICTION The White Tiger: A Novel • Aravind Adiga The Pregnant Widow • Martin Amis New York Trilogy • Paul Auster The Wettest County in the World: A Novel Based on a True Story • Matt Bondurant The Lost Symbol • Dan Brown Death Comes for the Archbishop • Willa Cather and A.S. Byatt Await Your Repl...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Lighter Moments
Michael Agard • Sanofi-Aventis US I was traveling for business in Paris with some colleagues. I had arranged a wake-up call with the hotel. My colleagues called about 1 a.m. to tell me about plans for the following day. Instead of listening to their phone call, I thought it was the wake-up call a...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The MENTORS
The MENTORS People’s People We salute those who take the time out of their own busy careers to help others to develop their paths to success; provide guidance; and exhibit patience, foresight, and unselfish devotion to mentoring. Knowledge is most valuable when shared, and Wendy Blackburn is one ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The TECHNOLOGISTS
Not many people have created two health-related companies, nor have had them both successfully acquired before their 30th birthday. But Hugo Stephenson, M.D., has an ability to see what others cannot and the energy to make things happens. As he says, he’s never yet met a challenge that could not ...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The CLINICAL SPECIALISTS
Patients have a powerful advocate in Craig Lipset. A recognized speaker and author on innovation in clinical trials and improving patient engagement in research, Mr. Lipset has recently been leading industry efforts around personalized medicine. An entrepreneurial and innovative individual, Mr. L...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
The CHANGE AGENTS
It was apparent from the start of his career that Leo Francis, Ph.D., was a leader in the making. From his early days in the industry, Dr. Francis’ professionalism and inexorable drive for excellence in all aspects of his work have shone through. His achievements have led to extraordinary progre...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
On The Calendar
July 15-16 Effective Document Management for the Pharmaceutical, Biotech & Medical Device Industries The Hilton Hotel, Orange County/ Costa Mesa, Calif. The Center for Professional Innovation and Education, http://www.cfpie.com/showitem.aspx?productid=027&source=pv July 15-16 Managed Care...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: FDA, NIH Launch Electronic Safety Reporting Portal Insurance Documentation System Helps Prevent Study Delays GSW Worldwide Unveils New Website and Blog Derycz Scientific Offers Solution for Electronic Article Reus...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Financial Disclosure Compliance is Still an Issue for Life-Sciences Firms Sidebars: Slow Outsourcing of Disclosure Reporting Sources for Adverse Event Reports Online Collection of Adverse Event Reports Lags Traditional M...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Who's on the List by Company
Anavex Life Sciences Cameron Durrant, M.D. 18 ApotheCom David Dunn 16 Astellas Pharma US Margaret Long 73 AstraZeneca David Brennan 46 bioCapture Johanna Allston, Ph.D. 12 C3i Robert Piwko 112 Cegedim Dendrite Angela Miccoli 74 Cipla Ltd. Yusuf Hamied, Ph.D. 19 ClearTrial Mike Soenen 29 closerloo...
By PharmaVoice Team • July 28, 2010 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The PharmaVOICE 100: 2010 Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-sciences industry. This special issue, n...
By Taren Grom • July 28, 2010 -
PharmaVoice Team/PharmaVoice
2010 DIA Preview
PharmaVOICE is pleased to once again publish this Special Feature showcasing the new products, services, tools, and executive appointments and promotions at clinical-services companies that will be exhibiting at the DIA 46th Annual Meeting, June 13-17, 2010, in Washington, D.C. For your convenie...
By PharmaVoice Team • May 24, 2010
Previous
